ZA201703078B - Pharmaceutical composition comprising bisoprolol and perindoril - Google Patents

Pharmaceutical composition comprising bisoprolol and perindoril

Info

Publication number: ZA201703078B
Authority: ZA; South Africa
Prior art keywords: perindoril; bisoprolol; pharmaceutical composition; pharmaceutical; composition
Prior art date: 2014-11-05

Application number

ZA201703078A

Inventor

Gilles Fonknechten

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-11-05

Filing date

2017-05-04

Publication date

2020-11-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52345359&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA201703078(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2017-05-04 Application filed by Servier Lab filed Critical Servier Lab

2020-11-25 Publication of ZA201703078B publication Critical patent/ZA201703078B/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Heart & Thoracic Surgery (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

ZA201703078A 2014-11-05 2017-05-04 Pharmaceutical composition comprising bisoprolol and perindoril ZA201703078B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR1460654A FR3027803B1 (en)	2014-11-05	2014-11-05	PHARMACEUTICAL COMPOSITION COMPRISING A BETABLOQUANT AND A CONVERSION ENZYME INHIBITOR
PCT/FR2015/052975 WO2016071631A1 (en)	2014-11-05	2015-11-04	Pharmaceutical composition comprising bisoprolol and perindoril

Publications (1)

Publication Number	Publication Date
ZA201703078B true ZA201703078B (en)	2020-11-25

Family

ID=52345359

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA201703078A ZA201703078B (en)	2014-11-05	2017-05-04	Pharmaceutical composition comprising bisoprolol and perindoril

Country Status (24)

Country	Link
EP (1)	EP3215130B1 (en)
CY (1)	CY1123322T1 (en)
DK (1)	DK3215130T3 (en)
EA (1)	EA032808B1 (en)
ES (1)	ES2811904T3 (en)
FR (1)	FR3027803B1 (en)
GE (1)	GEP20196989B (en)
HR (1)	HRP20201518T1 (en)
HU (1)	HUE051947T2 (en)
LT (1)	LT3215130T (en)
MA (1)	MA40915B1 (en)
MX (1)	MX2017005848A (en)
MY (1)	MY187357A (en)
PH (1)	PH12017500786B1 (en)
PL (1)	PL3215130T3 (en)
PT (1)	PT3215130T (en)
RS (1)	RS60657B1 (en)
RU (1)	RU2702362C2 (en)
SG (2)	SG11201703550SA (en)
SI (1)	SI3215130T1 (en)
TN (1)	TN2017000170A1 (en)
UA (1)	UA122131C2 (en)
WO (1)	WO2016071631A1 (en)
ZA (1)	ZA201703078B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA3234743A1 (en)	2021-10-20	2023-04-27	Les Laboratoires Servier	Novel trimetazidine salts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003092729A1 (en)	2002-05-03	2003-11-13	Hexal Ag	Stable pharmaceutical formulation for a combination of a statin and an ace inhibitor
WO2007010501A2 (en) *	2005-07-22	2007-01-25	Ranbaxy Laboratories Limited	A pharmaceutical composition comprising a combination of beta blocker and an ace inhibitor
HU230877B1 (en) *	2008-09-30	2018-11-29	EGIS Gyógyszergyár NyR	Stable pharmaceutical combination
EP2424509A4 (en) *	2009-04-30	2012-11-07	Reddys Lab Ltd Dr	Fixed dose drug combination formulations
EP2566472B1 (en)	2010-05-06	2015-01-07	Cal International Limited	A pharmaceutical composition comprising aspirin and bisoprolol

2014
- 2014-11-05 FR FR1460654A patent/FR3027803B1/en active Active
2015
- 2015-11-03 MA MA40915A patent/MA40915B1/en unknown
- 2015-11-04 EP EP15807949.1A patent/EP3215130B1/en not_active Revoked
- 2015-11-04 SI SI201531387T patent/SI3215130T1/en unknown
- 2015-11-04 LT LTEP15807949.1T patent/LT3215130T/en unknown
- 2015-11-04 MX MX2017005848A patent/MX2017005848A/en active IP Right Grant
- 2015-11-04 PL PL15807949T patent/PL3215130T3/en unknown
- 2015-11-04 MY MYPI2017701538A patent/MY187357A/en unknown
- 2015-11-04 SG SG11201703550SA patent/SG11201703550SA/en unknown
- 2015-11-04 HU HUE15807949A patent/HUE051947T2/en unknown
- 2015-11-04 RU RU2017115341A patent/RU2702362C2/en active
- 2015-11-04 DK DK15807949.1T patent/DK3215130T3/en active
- 2015-11-04 EA EA201790772A patent/EA032808B1/en unknown
- 2015-11-04 TN TN2017000170A patent/TN2017000170A1/en unknown
- 2015-11-04 WO PCT/FR2015/052975 patent/WO2016071631A1/en active Application Filing
- 2015-11-04 PT PT158079491T patent/PT3215130T/en unknown
- 2015-11-04 RS RS20200954A patent/RS60657B1/en unknown
- 2015-11-04 GE GEAP201514507A patent/GEP20196989B/en unknown
- 2015-11-04 SG SG10201903656RA patent/SG10201903656RA/en unknown
- 2015-11-04 UA UAA201705309A patent/UA122131C2/en unknown
- 2015-11-04 ES ES15807949T patent/ES2811904T3/en active Active
2017
- 2017-04-27 PH PH12017500786A patent/PH12017500786B1/en unknown
- 2017-05-04 ZA ZA201703078A patent/ZA201703078B/en unknown
2020
- 2020-09-07 CY CY20201100839T patent/CY1123322T1/en unknown
- 2020-09-23 HR HRP20201518TT patent/HRP20201518T1/en unknown

Also Published As

Publication number	Publication date
SG10201903656RA (en)	2019-05-30
PT3215130T (en)	2020-08-26
PH12017500786A1 (en)	2017-10-02
FR3027803A1 (en)	2016-05-06
SI3215130T1 (en)	2020-11-30
CY1123322T1 (en)	2021-12-31
FR3027803B1 (en)	2018-02-09
RU2702362C2 (en)	2019-10-08
DK3215130T3 (en)	2020-09-21
EA201790772A1 (en)	2017-09-29
HRP20201518T1 (en)	2020-12-11
UA122131C2 (en)	2020-09-25
MA40915B1 (en)	2020-08-31
PH12017500786B1 (en)	2017-10-02
RU2017115341A3 (en)	2019-05-21
GEP20196989B (en)	2019-07-10
SG11201703550SA (en)	2017-06-29
WO2016071631A1 (en)	2016-05-12
MY187357A (en)	2021-09-22
PL3215130T3 (en)	2020-11-16
TN2017000170A1 (en)	2018-10-19
LT3215130T (en)	2020-08-25
MX2017005848A (en)	2017-06-27
EP3215130A1 (en)	2017-09-13
EA032808B1 (en)	2019-07-31
EP3215130B1 (en)	2020-07-08
HUE051947T2 (en)	2021-03-29
RS60657B1 (en)	2020-09-30
RU2017115341A (en)	2018-11-05
ES2811904T3 (en)	2021-03-15

Publication	Publication Date	Title
HK1249103B (en)	2020-02-07	Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
HK1244000B (en)	2020-05-22	Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
IL252967A0 (en)	2017-08-31	Pharmaceutical composition comprising plasminogen and uses thereof
GB201409471D0 (en)	2014-07-09	Pharmaceutical composition
HK1245086A1 (en)	2018-08-24	Pharmaceutical composition preparation and uses thereof
GB201409488D0 (en)	2014-07-09	Pharmaceutical composition
GB201409485D0 (en)	2014-07-09	Pharmaceutical composition
ZA201703976B (en)	2019-06-26	Dihydropyrimidine-2-one compounds and medicinal uses thereof
ZA201703398B (en)	2019-01-30	Pharmaceutical composition and methods
HK1245085A1 (en)	2018-08-24	Pharmaceutical composition preparation and uses thereof
GB201406172D0 (en)	2014-05-21	Therapy and pharmaceutical composition
ZA201502073B (en)	2016-03-30	Pharmaceutical composition
ZA201508726B (en)	2017-03-29	Pharmaceutical composition
HUE050881T2 (en)	2021-01-28	Pharmaceutical composition
ZA201703078B (en)	2020-11-25	Pharmaceutical composition comprising bisoprolol and perindoril
SG10201504332VA (en)	2016-01-28	Pharmaceutical Composition